Kerendia 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FHQ0T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,979
Award facts
- Contract value 100% obligated
- $14,979.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract valued at $14,979.25. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical support for military healthcare programs worldwide.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, supplying a broad range of medications, vaccines, and medical supplies to military and veteran healthcare systems. The delivery order for Kerendia, a medication used in diabetes and kidney disease management, exemplifies the company's role in supporting Defense Health Agency operations and other federal healthcare customers. As a major pharmaceutical distributor with demonstrated capability to meet federal procurement requirements through open competition, AmerisourceBergen maintains a substantial portfolio of delivery orders with the Defense Logistics Agency covering diverse therapeutic domains and product categories, with an ultimate completion date of November 14, 2025.
Quick answers
Who was awarded contract SPE2DR26FHQ0T?
SPE2DR26FHQ0T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FHQ0T worth?
The government has obligated $14,979 on SPE2DR26FHQ0T.
Is contract SPE2DR26FHQ0T an order under another contract?
Yes. SPE2DR26FHQ0T is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHQ0T competed?
The extent of competition for SPE2DR26FHQ0T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award